Extralymphatic Disease Is An Independent Prognostic Factor In Hodgkin ’s Lymphomas

This study aims to identify the characteristics and outcomes of patients with extralymphatic HL. We performed a retrospective single institution study of 341 cases (207 (61%) males and 134 (39%) females) with a median follow-up of 44 months; 55 patients (16%) had extralymphatic disease. The sites were the lung in 29 patients (44%), bone in 22 (33%), liver in 5 (18%) and kidney in 3 (5%). In 46 patients (86%) only one organ was involved, while in 7 patients (13%) extralymphatic disease was present in 2 sites and in 2 patients (3%) in 3 sites.

Source: Clinical Lymphoma, Myeloma and Leukemia - April 13, 2018 Category: Hematology Authors: Francesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, Tommasina Perrone, Filomena Emanuela Laddaga, Vito Pier Gagliardi, Antonia Cimmino, Dario D ’abbicco, Angela Pezzolla, Giuseppe Rubini, Giorgina Specchia Tags: Original Study Source Type: research